Research and Development

Amgen and UCB SA have been delivered a crushing blow in its attempt to have a drug for osteoporosis approved …

Research from the NYU Langone Medical Center and its Perlmutter Cancer Center, based in New York City, has indicated that …

With every week we draw closer to the event everyone in the UK is talking about – the general election. …

Researchers from Brigham and Women’s Hospital and Harvard Medical School have conducted a small-scale study into the prospect of using …

The FDA has announced that it has approved Mitsubishi Tanabe Pharma’s Radicava (edaravone) for the treatment of amyotrophic lateral sclerosis(ALS), …

The opioid crisis that is currently gripping North America is gaining more and more news traction as the damage to …

AstraZeneca has launched a lawsuit against one of its former executives after he jumped ship to join rival pharma giant …

Bayer has announced that its investigational blood cancer treatment copanlisib has been awarded priority review designation from the FDA, meaning …

T cells are widely known as being crucial in the fight against cancer within the body but little was known, …

Johnson & Johnson has found itself in deep water again over the potentially harmful effects of its products. This time …

Sangamo Therapeutics has announced that the FDA has granted its cDNA gene therapy candidate for haemophilia A Fast Track Designation. …

Beta interferons are a common treatment used to manage multiple sclerosis. The treatment works by reducing and preventing the inflammation …

Ionis Pharmaceuticals announced the results from a Phase 3 trial of its drug to treat patients with familial amyloid polyneuropathy …

The health care system in Cuba is widely held up to be a model of innovation; despite severe economic  sanctions …

The regulatory and drug approval process is destined to change once the UK leaves the EU. The problem is, nobody …